This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
→Proposed method of action: Changed Patent names of SSRI's to the generic equivalents as most people would recognise the generic names, as they are more commonly prescribed in many countries (especially in the United Kingdom). In relation to potential harm reduction for the reader of the article, this edit allows for more easier and faster recognition of SSRI's that possibly affect the dosage of Serotonergic Psychedelics.
(38 intermediate revisions by 3 users not shown)
Line 10:
Line 10:
[[File:Lsd brain scan.jpg|thumbnail|315px|right|This image shows how, with eyes-closed, much more of the brain contributes to the visual experience under LSD (right image) than under placebo (left image). The magnitude of this effect correlates with participants’ reports of complex, dreamlike visions.<ref>Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., … Nutt, D. J. (2016). Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1518377113</ref>]]
[[File:Lsd brain scan.jpg|thumbnail|315px|right|This image shows how, with eyes-closed, much more of the brain contributes to the visual experience under LSD (right image) than under placebo (left image). The magnitude of this effect correlates with participants’ reports of complex, dreamlike visions.<ref>Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., … Nutt, D. J. (2016). Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1518377113</ref>]]
While the method of action of serotonergic psychedelics is not fully understood, serotonergic psychedelics are known to show affinities for various 5-HT receptors in different ways and levels, and may be classified by their activity at different 5-HT sub-sites, such as 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, 5-HT<sub>2A</sub>, etc.
While the full mechanism of action is not understood, serotonergic psychedelics are known to exhibit [[partial agonism|partial agonist activity]] for various 5-HT receptors in a range of affinities and efficacies. As a result, they may be classified by their activity at different 5-HT sub-sites, such as 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, 5-HT<sub>2A</sub>, etc.
Many serotonergic psychedelics, such as the family of [[tryptamines]], have very strong structural similarities to serotonin itself, which partially explains the affinity for certain 5-HT sites. It is almost unanimously agreed that most serotonergic psychedelics produce their effect by acting as strong partial [[agonists]] at the 5-HT<sub>2A</sub> receptors.{{citation needed}}
Many serotonergic psychedelics, such as the family of [[tryptamines]], have very strong structural similarities to serotonin itself. This partially explains the affinity they have for certain 5-HT sites. Most research suggests that the signature psychedelic effect is due to strong partial [[agonist]] activity at the 5-HT<sub>2A</sub>, and to a lesser extent, 5-HT<sub>2C</sub> and 5-HT<sub>1A</sub> receptors.{{citation needed}}
The cortico-striato-thalamo-cortical loops (also known as CSTC-loops) seem to be central to the function of psychedelics<ref>Taylor, S. B., Lewis, C. R., & Olive, M. F. (2013). The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans. Substance Abuse and Rehabilitation, 4, 29–43. https://doi.org/10.2147/SAR.S39684; [..] The overall output of the basal ganglia is predominantly via the thalamus, which then projects back to the PFC to form cortico-striatal-thalamo-cortical (CSTC) loops. [..]</ref>, which are also regulated by the serotonergic system. These control loops connect brain areas like the frontal lobe, the striatum and the thalamus; they aggregate, process and forward internal and external information.
The cortico-striato-thalamo-cortical loops (also known as CSTC-loops) appear to be central to the function of psychedelics,<ref>Taylor, S. B., Lewis, C. R., & Olive, M. F. (2013). The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans. Substance Abuse and Rehabilitation, 4, 29–43. https://doi.org/10.2147/SAR.S39684; [..] The overall output of the basal ganglia is predominantly via the thalamus, which then projects back to the PFC to form cortico-striatal-thalamo-cortical (CSTC) loops. [..]</ref> which are also regulated by the serotonergic system. These control loops connect brain areas like the frontal lobe, the striatum and the thalamus; they aggregate, process and forward internal and external information.
The disruption of the neurotransmitter balance causes these control loops to collapse overwhelmed, leading to the flooding of the frontal lobe with neuronal excitatory glutamate; internal and external stimuli as well as all kinds of non-conscious contents can freely move up to the cerebral cortex and appear as visions in consciousness.<ref>Vollenweider, F. X. (2001). Brain mechanisms of hallucinogens and entactogens. Dialogues in Clinical Neuroscience, 3(4), 265–79. Retrieved from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3181663&tool=pmcentrez&rendertype=abstract</ref><ref>[http://www.neuroculturelab.com/portfolio/edelrausch-im-labor/ Edelrausch im Labor] – ''Neuro Culture Lab'' (German)</ref>
The disruption of the neurotransmitter balance causes these control loops to collapse overwhelmed, leading to the flooding of the frontal lobe with neuronal excitatory glutamate; internal and external stimuli as well as all kinds of non-conscious contents can freely move up to the cerebral cortex and appear as visions in consciousness.<ref>Vollenweider, F. X. (2001). Brain mechanisms of hallucinogens and entactogens. Dialogues in Clinical Neuroscience, 3(4), 265–79. Retrieved from https://doi.org/10.31887/DCNS.2001.3.4/fxvollenweider</ref><ref>[http://archive.today/jcBm Edelrausch im Labor] – ''Neuro Culture Lab'' (German)</ref>
Furthermore, there is an over-activation of the locus coerlueus and thereby widespread [[norepinephrine]] secretion, causing a state of spiritual transcendence and sometimes even intense spiritual experiences.
Furthermore, over-activation of the ''locus coeruleus'' and subsequent widespread [[norepinephrine]] secretion may occur, causing a perceived state of sensory transcendence and sometimes even intense spiritual or [[transpersonal]] experiences.
Worth noting is that [[selective serotonin reuptake inhibitor]]s (a class of [[antidepressants]] including Paxil, Prozac, and Zoloft) can increase the dosage required for hallucinogenic effects of serotonergic psychedelics in some people based on anecdotal reports. Some users, however, have found this to be entirely untrue for them, so users who are using daily antidepressants should, at first, only attempt a common dosage.
It is worth noting that [[selective serotonin reuptake inhibitors]] (a class of [[antidepressants]] including Paroxetine, Fluoxetine and Sertraline) can increase the dosage required for hallucinogenic effects in some people (based on anecdotal reports). Some users, however, have found this to be entirely untrue for them, so those who are using daily antidepressants should, at first, only attempt a common dosage.
* Nichols, C. D., & Sanders-Bush, E. (2001). "Serotonin Receptor Signaling and Hallucinogenic Drug Action". Heffter Rev Psychedelic Res, 2, 73-79. https://web-beta.archive.org/web/20170110205041/https://heffter.org/docs/hrireview/02/chap5.pdf
* {{cite journal|last1=Halberstadt|first1=Adam L.|title=Recent advances in the neuropsychopharmacology of serotonergic hallucinogens|journal=Behavioural Brain Research|volume=277|year=2015|pages=99–120|issn=01664328|doi=10.1016/j.bbr.2014.07.016}}
*Nichols, C. D., & Sanders-Bush, E. (2001). "Serotonin Receptor Signaling and Hallucinogenic Drug Action". Heffter Rev Psychedelic Res, 2, 73-79. https://web-beta.archive.org/web/20170110205041/https://heffter.org/docs/hrireview/02/chap5.pdf
* {{cite journal|last1=Beique|first1=J.-C.|last2=Imad|first2=M.|last3=Mladenovic|first3=L.|last4=Gingrich|first4=J. A.|last5=Andrade|first5=R.|title=Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex|journal=Proceedings of the National Academy of Sciences|volume=104|issue=23|year=2007|pages=9870–9875|issn=0027-8424|doi=10.1073/pnas.0700436104}}
*{{cite journal|last1=Halberstadt|first1=Adam L.|title=Recent advances in the neuropsychopharmacology of serotonergic hallucinogens|journal=Behavioural Brain Research|volume=277|year=2015|pages=99–120|issn=01664328|doi=10.1016/j.bbr.2014.07.016}}
* {{cite journal|last1=Winter|first1=J.C|last2=Fiorella|first2=D.J|last3=Timineri|first3=D.M|last4=Filipink|first4=R.A|last5=Helsley|first5=S.E|last6=Rabin|first6=R.A|title=Serotonergic Receptor Subtypes and Hallucinogen-Induced Stimulus Control|journal=Pharmacology Biochemistry and Behavior|volume=64|issue=2|year=1999|pages=283–293|issn=00913057|doi=10.1016/S0091-3057(99)00063-5}}
*{{cite journal|last1=Beique|first1=J.-C.|last2=Imad|first2=M.|last3=Mladenovic|first3=L.|last4=Gingrich|first4=J. A.|last5=Andrade|first5=R.|title=Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex|journal=Proceedings of the National Academy of Sciences|volume=104|issue=23|year=2007|pages=9870–9875|issn=0027-8424|doi=10.1073/pnas.0700436104}}
*{{cite journal|last1=Winter|first1=J.C|last2=Fiorella|first2=D.J|last3=Timineri|first3=D.M|last4=Filipink|first4=R.A|last5=Helsley|first5=S.E|last6=Rabin|first6=R.A|title=Serotonergic Receptor Subtypes and Hallucinogen-Induced Stimulus Control|journal=Pharmacology Biochemistry and Behavior|volume=64|issue=2|year=1999|pages=283–293|issn=00913057|doi=10.1016/S0091-3057(99)00063-5}}
* Canal, C. E., & Murnane, K. S. (2017). The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens. Journal of Psychopharmacology, 31(1), 127-143. https://doi.org/10.1177/0269881116677104
*Canal, C. E., & Murnane, K. S. (2017). The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens. Journal of Psychopharmacology, 31(1), 127-143. https://doi.org/10.1177/0269881116677104
==References==
==References==
<references/>
<references />
[[Category:Psychedelic]]
[[Category:Psychedelic]]
Latest revision as of 07:12, 10 March 2024
Psychedelic structural comparison diagram
Serotonergic psychedelics (also known as serotonergic hallucinogens) are a class of hallucinogenic substances with a method of action strongly tied to modifying the normal neurotransmission of serotonin in the central nervous system (CNS).
Serotonin, which is also referred to as 5-HT (from its chemical name 5-hydroxy-tryptamine), is a naturally-occurring monoamine neurotransmitter that is tied to functions including developmental, cardiovascular, gastrointestinal, and endocrine function, sensory perception, behaviors such as aggression, appetite, sex, sleep, mood, cognition, and memory, many of which have yet to be fully understood.[1]
The diagram above demonstrates the neural connections associated with sobriety in comparison to being under the influence of psilocybin as demonstrated through the use of MRI scans.
The width of the links is proportional to their weight and the size of the nodes is proportional to their strength. Note that the proportion of heavy links between communities is much higher (and very different) in the psilocybin group, suggesting greater integration[2]
Figure 1 - The figure shows a model in which hallucinogens, such as psilocin, LSD and DMT, increase extracellular glutamate levels in the prefrontal cortex through stimulation of postsynaptic serotonin 2A (5-HT 2A) receptors that are located on large glutamatergic pyramidal cells in deep cortical layers (V and VI) projecting to layer V pyramidal neurons.
This glutamate release leads to an activation of AMPA and NMDA receptors on cortical pyramidal neurons. In addition, hallucinogens directly activate 5-HT2A receptors located on cortical pyramidal neurons. This activation is thought to ultimately lead to increased expression of brain-derived neurotrophic factor (BDNF).[3]
This image shows how, with eyes-closed, much more of the brain contributes to the visual experience under LSD (right image) than under placebo (left image). The magnitude of this effect correlates with participants’ reports of complex, dreamlike visions.[4]
While the full mechanism of action is not understood, serotonergic psychedelics are known to exhibit partial agonist activity for various 5-HT receptors in a range of affinities and efficacies. As a result, they may be classified by their activity at different 5-HT sub-sites, such as 5-HT1A, 5-HT1B, 5-HT2A, etc.
Many serotonergic psychedelics, such as the family of tryptamines, have very strong structural similarities to serotonin itself. This partially explains the affinity they have for certain 5-HT sites. Most research suggests that the signature psychedelic effect is due to strong partial agonist activity at the 5-HT2A, and to a lesser extent, 5-HT2C and 5-HT1A receptors.[citation needed]
The cortico-striato-thalamo-cortical loops (also known as CSTC-loops) appear to be central to the function of psychedelics,[5] which are also regulated by the serotonergic system. These control loops connect brain areas like the frontal lobe, the striatum and the thalamus; they aggregate, process and forward internal and external information.
The disruption of the neurotransmitter balance causes these control loops to collapse overwhelmed, leading to the flooding of the frontal lobe with neuronal excitatory glutamate; internal and external stimuli as well as all kinds of non-conscious contents can freely move up to the cerebral cortex and appear as visions in consciousness.[6][7]
Furthermore, over-activation of the locus coeruleus and subsequent widespread norepinephrine secretion may occur, causing a perceived state of sensory transcendence and sometimes even intense spiritual or transpersonal experiences.
It is worth noting that selective serotonin reuptake inhibitors (a class of antidepressants including Paroxetine, Fluoxetine and Sertraline) can increase the dosage required for hallucinogenic effects in some people (based on anecdotal reports). Some users, however, have found this to be entirely untrue for them, so those who are using daily antidepressants should, at first, only attempt a common dosage.
Halberstadt, Adam L. (2015). "Recent advances in the neuropsychopharmacology of serotonergic hallucinogens". Behavioural Brain Research. 277: 99–120. doi:10.1016/j.bbr.2014.07.016. ISSN0166-4328.
Beique, J.-C.; Imad, M.; Mladenovic, L.; Gingrich, J. A.; Andrade, R. (2007). "Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex". Proceedings of the National Academy of Sciences. 104 (23): 9870–9875. doi:10.1073/pnas.0700436104. ISSN0027-8424.
Nichols, David E.; Nichols, Charles D. (2008). "Serotonin Receptors". Chemical Reviews. 108 (5): 1614–1641. doi:10.1021/cr078224o. ISSN0009-2665.
Canal, C. E., & Murnane, K. S. (2017). The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens. Journal of Psychopharmacology, 31(1), 127-143. https://doi.org/10.1177/0269881116677104
References
↑David E. Nichols and Charles D. Nichols, Serotonin Receptors. Chemical Reviews. 2008. 108 (5), 1614-1641. https://doi.org/10.1021/cr078224o
↑Petri, G., Expert, P., Turkheimer, F., Nutt, D., Hellyer, P. J., & Vaccarino, F. (2014). Homological scaffolds of brain functional networks, 14–18. https://doi.org/10.1098/rsif.2014.0873
↑Vollenweider, F. X., & Kometer, M. (2010). The Neurobiology of Psychedelic Drugs: Implications for the Treatment of Mood Disorders. Nature Publishing Group, 11(9), 642–651. https://doi.org/10.1038/nrn2884
↑Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., … Nutt, D. J. (2016). Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1518377113
↑Taylor, S. B., Lewis, C. R., & Olive, M. F. (2013). The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans. Substance Abuse and Rehabilitation, 4, 29–43. https://doi.org/10.2147/SAR.S39684; [..] The overall output of the basal ganglia is predominantly via the thalamus, which then projects back to the PFC to form cortico-striatal-thalamo-cortical (CSTC) loops. [..]
